Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Other financing activities (2018)

X4 Pharmaceuticals' Other financing activities history spans 1 years, with the latest figure at $43000.0 for Q1 2018.

  • For Q1 2018, Other financing activities changed N/A year-over-year to $43000.0; the TTM value through Dec 2018 reached $43000.0, changed N/A, while the annual FY2018 figure was $43000.0, 99.34% down from the prior year.
  • Other financing activities reached $43000.0 in Q1 2018 per XFOR's latest filing.
  • In the past five years, Other financing activities ranged from a high of $43000.0 in Q1 2018 to a low of $43000.0 in Q1 2018.